“…l ‐malate can also be used to treat hyperammonemia and liver dysfunction as a component of amino acid infusions (Battat, Peleg, Bercovitz, Rokem, & Goldberg, ). Recently, l ‐malate has been produced by natural or genetically engineered microbes, including Clostridium formicoaceticum (Dorn, Andreesen, & Gottschalk, ), Aspergillus flavus (Battat et al, ; Peleg, Stieglitz, & Goldberg, ), Saccharomyces cerevisiae (Nakayama et al, ; Schwartz & Radler, ; Zelle et al, ), Escherichia coli (Moon, Hong, & Kim, ; Zhang, Wang, Shanmugam, & Ingram, ), Rhizopus delemar (Dörsam et al, ; Li et al, ), and Ustilago trichophora (Zambanini et al, ). However, these producers have some shortcomings, such as aflatoxin accumulation, long fermentation time, and process unstability, which limit their application in industrial scale.…”